Search
Close this search box.

HIV Management Guide for Clinical Care

HIV Management Guide for Clinical Care

Search
Close this search box.

Nurses & Midwives

Management > Nurses & Midwives > References

Sections

Sections

References

  1. Osterberg L and Blaschke T.  Adherence to Medication. N Engl J Med 2005; 353:487, August 4.  
  2. García de Ollala P, Knobel H, Carmona A, Guelar A, López-Colomés JL, and Caylà JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 1999; 30(1): 105-110.  
  3. Mille W, Powers K, Smith M, Cohen M. Community viral load as a measure for assessment of HIV treatment as prevention. The Lancet Infect Dis, 2013; 13(5): 459.  
  4. García de Ollala P, Knobel H, Carmona A, Guelar A, López-Colomés JL, and Caylà JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 1999; 30(1): 105-110.  
  5. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5: e11068  
  6. El-Sadr W, Lundgren, JD, Neaton J, Gordin F, Abrams D, Arduino, R., . . . Cohen, C. CD4+ count-guided interruption of antiretroviral treatment. New Engl J Med 2006; 355(22): 2283-2296.  
  7. Remien RH, Bauman LJ, Mantell JE, Tsoi B, Lopez-Rios J, Chhabra, R., . . . Teitelman, N. Barriers and facilitators to engagement of vulnerable populations in HIV primary care in New York City. JAIDS Journal of Acquired Immune Deficiency Syndromes 2015; 69: S16-S24.  
  8. Mbuagbaw L, Sivaramalingam B, Navarro T, Hobson N, Keepanasseril A, Wilczynski NJ, Haynes RB. Interventions for Enhancing Adherence to Antiretroviral Therapy (ART): A Systematic Review of High-Quality Studies. AIDS Patient Care and STDs 2015; 29(5): 248-266.  
  9. Mao L, Wit J, Kippax S, Prestage G, Holt, M. Younger age, recent HIV diagnosis, no welfare support, and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV‐positive gay men in Australia. HIV Medicine, 2015; 16(1): 32-37.  
  10. WHO. Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). Geneva: WHO; 2006.  
  11. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015 Aug 27; 373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.  
  12. Eisinger RW, Dieffenbach CW, Fauci AS. HIV Viral Load and Transmissibility of HIV Infection. JAMA. 2019 Feb 5;321(5):451. 
  13. ‌International AIDS Society (IAS) IAS statement on U=U: Putting the science into action | International AIDS Society (IAS) (iasociety.org) (accessed March 2024)  
  14. 1 Grierson J, Koelmeyer RL, Smith A, Pitts, M.  Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.  HIV Medicine 12; Issue 9:562–569, October.  
  15. Weerasuria M, Ko C, Ehm A, O’Bryan J, McMahon J, Woolley I, et al. The Impact of the COVID-19 Pandemic on People Living with HIV in Victoria, Australia. AIDS Research and Human Retroviruses. 2021 Apr 1;37(4):322–8. 
  16. Lee D, Chow EPF, Aguirre I, Fairley CK, Ong JJ. Access to HIV Antiretroviral Therapy among People Living with HIV in Melbourne during the COVID-19 Pandemic. International Journal of Environmental Research and Public Health. 2021 Dec 3;18(23):12765.  
  17. El-Sadr W, Lundgren, JD, Neaton J, Gordin F, Abrams D, Arduino, R., . . . Cohen, C. CD4+ count-guided interruption of antiretroviral treatment. New Engl J Med 2006; 355(22): 2283-2296.  
  18. Langebeek N, Sprenger H, Gisolf E, Reiss P, Sprangers M, Legrand J, . . . Nieuwkerk A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. HIV Medicine 2014; 15(5), 286‐290.  
  19. O’Connor JL, Gardner EM, Mannheimer SB, Lifson A, Essex S, Telzah EE, Phillips AN for the INSIGHT SMART Study group. JID 2013:208:40-9.  
  20. McMahon JH, Jordan MR, Kelley K, Bertagnolio S, Hong SY, Wanke CA, Lewin SR, Elliott JH. Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment Monitoring. Clin Inf Di, 2011 Feb 15; 52; 4:493-506. doi: 10.1093/cid/ciq167. Epub 2011 Jan 18.  
  21. Grierson J, Koelmeyer RL, Smith  Pitts, M Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.  HIV Medicine. 2011; 12(9):562–569, October.  
  22. Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S, Levine A, Durvasula R. Age-Associated Predictors of Medication Adherence in HIV Positive Adults: Health Beliefs, Self-Efficacy, and Neurocognitive Status. Health Psychol 2007; 26(1): 40–49, January. doi:10.1037/0278-6133.26.1.40  
  23. Bogart, L, Kalichman, SC and Simbayii, L. Endorsement of a genocidal HIV conspiracy as a barrier to HIV testing in South Africa. Journal of Acquired Immune Deficiency Syndromes, 2008; 49: 115-116.  
  24. Wringe Doubt, denial, and divine intervention: understanding delayed attendance and poor retention rates at an HIV treatment programme in rural Tanzania. AIDS Care, 2009; 21(5): 632-637.  
  25. Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral adherence in persons living with HIV/AIDS. Journal of General Internal Medicine 2009, October; 24:1101  
  26. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, Tsai AC. Impact of HIV-related stigma on treatment adherence: systematic review and meta-analysis. J Int AIDS Soc 2013; 16(3 Suppl 2): 18640. Doi: 10.7448/IAS. 16.3.18640.  
  27. McAllister J Beardsworth G, Lavie E, MacRae K, Carr A Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting. HIV Med. 2013 Feb;14(2):120-4. doi: 10.1111/j.1468-1293.2012. x. Epub 2012 Jul 10.  
  28. Australian Government Department of Human Services. 2024. Pharmaceutical Benefits Scheme (PBS) | The Closing the Gap (CTG) – PBS Co-payment Program (accessed March 2024)
  29. Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S, Levine A, Durvasula R. Age-Associated Predictors of Medication Adherence in HIV Positive Adults: Health Beliefs, Self-Efficacy, and Neurocognitive Status. Health Psychol 2007; 26(1): 40–49, January. doi:10.1037/0278-6133.26.1.40  
  30. Mellins C, Kang E, Leu C-S, Havens J, Chesney M. AIDS Patient Care and STDs 2003, 17(8): 407-416, August.  
  31. Lesserman, J. Role of Depression, Stress and Trauma in HIV Disease Progression. Psychosomatic Medicine. 2008 70 (5), 539-545, June.  
  32. Reback CJ, Larkins S and Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003; 15(6):775-85.  
  33. Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S, Levine A, Durvasula R. Age-Associated Predictors of Medication Adherence in HIV Positive Adults: Health Beliefs, Self-Efficacy, and Neurocognitive Status. Health Psychol 2007; 26(1): 40–49, January. doi:10.1037/0278-6133.26.1.40  
  34. Kalichman, SC, Ramachandran, C and Catz, S. Adherence to combination antiretroviral therapies in HIV seropositive men and women of low health literacy. Journal of General Internal Medicine. 1999; 14:267-273.  
  35. Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care & STDs 2006; 20(5):359‐  
  36. In a conversation with Judy Frecker (February 2016).  
  37. Schnall RW. Feasibility testing of a web-based symptom self-management system for persons living with HIV. JANAC 2014; 25; 4:364-371.  
  38. AIDS Info. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Limitations to Treatment Safety and Efficacy. Adherence to Antiretroviral Therapy (Last updated: May 1, 2014; last reviewed: May 1, 2014).  
  39. Grossman CI, Stangl AL. Editorial: Global action to reduce HIV stigma and discrimination Article in Journal of the International AIDS Society 2013; 16(3) Suppl 2, November.  
  40. Young, IM. Justice and the Politics of Difference. New Jersey: Princeton University Press. 1990.  
  41. Cheek, J and Rudge, T. Been there, done that? Consciousness-raising, critical theory, and nurses.  Contemporary Nurse, 1994; 3(2):58-63, June.  
  42. Carcelero E, Tuset M, Martin M, De Lazzari E, Codina C, Miró J, GatellHIV Med. Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients. 2011 Sep; 12(8):494-9. doi: 10.1111/j.1468-1293.2011.00915. x. Epub 2011 Mar 13.  
  43. Faragon Antiretroviral medication errors in patients with HIV infection. University of Tennessee Advanced Studies in Pharmacy, 2006;3:5:179-186.  
  44. Daniels LM, Durham C. Clinical Review:  Interventions to Prevent and Correct Antiretroviral Medication Errors in Patients with HIV. JCOM 2016; 23:1:13-21.  
  45. Commers T, Swindell S, Sayles H, Gross AE, Devetten M, Sandovsky Antiretroviral medication prescribing errors are common with hospital admission of HIV-infected patients. J Antimicrob Chemother 2014; Jan; 69(1):262-7. doi: 10.1093/jac/dkt323. Epub 2013 Aug 16.  
  46. Duguld M The importance of medication reconciliation for patients and practitioners. Australian Prescriber 2012; 35; 1:15-19, February.  
  47. El-Sadr W, Lundgren, JD, Neaton J, Gordin F, Abrams D, Arduino, R., . . . Cohen, C. CD4+ count-guided interruption of antiretroviral treatment. New Engl J Med 2006; 355(22): 2283-2296  
  48. Langebeek N, Sprenger H, Gisolf E, Reiss P, Sprangers M, Legrand J, . . . Nieuwkerk P. A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. HIV Medicine 2014; 15(5), 286‐290.  
  49. Lifson A, Grandits G, Gardner E, Wolff M, Pulik P, Williams I, Barman W. Quality of life assessment among HIV‐positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine 2015; 16(S1): 88-96.  
  50. Broyles LN, Luo R, Boeras D, Vojnov L. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review. The Lancet [Internet]. 2023 Jul 22; Available from: https://www.sciencedirect.com/science/article/pii/S0140673623008772?via%3Dihub 
  51. Molina, J., Capitant, C., Charreau, I., Meyer, L., Spire, B., & Pialoux, G. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay Paper presented at the Conference on Retroviruses and Opportunistic Infections. Seattle, WA, 2015. 

Developing a sustainable HIV, Viral Hepatitis and Sexual Health Workforce

Information

About ASHMFeedback
Glossary of TermsPrivacy Policy
AcknowledgementsDisclosure Statements

Acknowledgement of Country

We pay our respects to the Aboriginal and Torres Strait Islander peoples of the past, present, and future, including the Gadigal peoples (Sydney office), the Turrbal and Jagera/Yuggera peoples (Brisbane office), and all First Nations people of the nations where we live and work.

ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM

Scroll to Top